Estimation of the marginal survival time in the presence of dependent competing risks using inverse probability of censoring weighted (IPCW) methods
- PMID: 17554753
- DOI: 10.1002/pst.290
Estimation of the marginal survival time in the presence of dependent competing risks using inverse probability of censoring weighted (IPCW) methods
Abstract
In medical studies, there is interest in inferring the marginal distribution of a survival time subject to competing risks. The Kyushu Lipid Intervention Study (KLIS) was a clinical study for hypercholesterolemia, where pravastatin treatment was compared with conventional treatment. The primary endpoint was time to events of coronary heart disease (CHD). In this study, however, some subjects died from causes other than CHD or were censored due to loss to follow-up. Because the treatments were targeted to reduce CHD events, the investigators were interested in the effect of the treatment on CHD events in the absence of causes of death or events other than CHD. In this paper, we present a method for estimating treatment group-specific marginal survival curves of time-to-event data in the presence of dependent competing risks. The proposed method is a straightforward extension of the Inverse Probability of Censoring Weighted (IPCW) method to settings with more than one reason for censoring. The results of our analysis showed that the IPCW marginal incidence for CHD was almost the same as the lower bound for which subjects with competing events were assumed to be censored at the end of all follow-up. This result provided reassurance that the results in KLIS were robust to competing risks.
Similar articles
-
Estimation of treatment effect adjusting for dependent censoring using the IPCW method: an application to a large primary prevention study for coronary events (MEGA study).Clin Trials. 2007;4(4):318-28. doi: 10.1177/1740774507081224. Clin Trials. 2007. PMID: 17848493 Clinical Trial.
-
Estimation of treatment effect adjusting for treatment changes using the intensity score method: application to a large primary prevention study for coronary events (MEGA study).Stat Med. 2008 May 10;27(10):1718-33. doi: 10.1002/sim.3065. Stat Med. 2008. PMID: 17922525
-
Survival analysis using inverse probability of treatment weighted methods based on the generalized propensity score.Pharm Stat. 2010 Jan-Mar;9(1):21-34. doi: 10.1002/pst.365. Pharm Stat. 2010. PMID: 19199275
-
Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications.Med Care. 2010 Jun;48(6 Suppl):S96-105. doi: 10.1097/MLR.0b013e3181d99107. Med Care. 2010. PMID: 20473207 Review.
-
Comparison of dynamic treatment regimes via inverse probability weighting.Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):237-42. doi: 10.1111/j.1742-7843.2006.pto_329.x. Basic Clin Pharmacol Toxicol. 2006. PMID: 16611197 Review.
Cited by
-
Tuberculosis treatment and risk of stavudine substitution in first-line antiretroviral therapy.Clin Infect Dis. 2009 Jun 1;48(11):1617-23. doi: 10.1086/598977. Clin Infect Dis. 2009. PMID: 19385733 Free PMC article.
-
A comparison of ad hoc methods to account for non-cancer AIDS and deaths as competing risks when estimating the effect of HAART on incident cancer AIDS among HIV-infected men.J Clin Epidemiol. 2010 Apr;63(4):459-67. doi: 10.1016/j.jclinepi.2009.08.003. Epub 2009 Oct 31. J Clin Epidemiol. 2010. PMID: 19880284 Free PMC article.
-
Double inverse-weighted estimation of cumulative treatment effects under nonproportional hazards and dependent censoring.Biometrics. 2011 Mar;67(1):29-38. doi: 10.1111/j.1541-0420.2010.01449.x. Biometrics. 2011. PMID: 20560935 Free PMC article.
-
Prediction meets causal inference: the role of treatment in clinical prediction models.Eur J Epidemiol. 2020 Jul;35(7):619-630. doi: 10.1007/s10654-020-00636-1. Epub 2020 May 22. Eur J Epidemiol. 2020. PMID: 32445007 Free PMC article.
-
Benefits and Harms of Standard Versus Reduced-Dose Direct Oral Anticoagulant Therapy for Older Adults With Multiple Morbidities and Atrial Fibrillation.J Am Heart Assoc. 2023 Nov 7;12(21):e029865. doi: 10.1161/JAHA.122.029865. Epub 2023 Nov 6. J Am Heart Assoc. 2023. PMID: 37929769 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical